ADVANCED MALIGNANT NEOPLASM
Clinical trials for ADVANCED MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat leukemia: first human trial of ziftomenib launches
Disease control OngoingThis early-stage trial tests a new drug called ziftomenib (KO-539) in people whose acute myeloid leukemia (AML) has returned or not responded to standard treatments. The study aims to find the safest and most effective dose, and to see if the drug can shrink or control the cancer…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
New drug shows promise for rare joint tumor – but not a cure
Disease control OngoingThis study tests an experimental drug called vimseltinib in people with a rare joint tumor (TGCT) or advanced solid tumors. The goal is to find the safest dose and see if it shrinks tumors or improves symptoms. About 120 adults will take part. This is not a cure – the drug aims t…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Electric field device joins chemo in fight against liver tumors
Disease control OngoingThis early-phase study tests a portable device that creates electric fields to disrupt cancer cell growth, combined with chemotherapy and a targeted antibody, in people whose cancer has spread to the liver and hasn't responded to standard treatments. The main goal is to find the …
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for hard-to-treat cancers with BRCA gene changes
Disease control OngoingThis study tests a drug called talazoparib in 150 adults whose advanced cancer has stopped responding to standard treatments. The drug works by blocking an enzyme that helps tumor cells survive, and is given to people whose tumors have specific changes in BRCA or related genes. T…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Can common drugs tame delirium in dying cancer patients?
Symptom relief OngoingThis study looks at whether haloperidol, given alone or with chlorpromazine, can safely reduce severe agitation and confusion (delirium) in advanced cancer patients in a palliative care unit. About 70 participants will receive the drugs and be monitored for 24 hours. The goal is …
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:55 UTC
-
Exercise plus steroid shows promise for cancer fatigue
Symptom relief OngoingThis study tests whether adding a short course of the steroid dexamethasone to a physical activity program can better reduce cancer-related fatigue in people with advanced cancer. About 90 participants will be randomly assigned to receive either a high or low dose of dexamethason…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:48 UTC
-
Needle in the spine offers hope for unbearable cancer pain
Symptom relief OngoingThis study tests a procedure called cordotomy to reduce severe pain in people with advanced cancer. Using a needle guided by CT scans, doctors target nerves in the spinal cord to block pain signals. The trial includes 27 adults with uncontrolled pain on one side of the body below…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Fatigue-Busting combo: drug and exercise tested in cancer patients
Symptom relief OngoingThis study looks at whether a medication called methylphenidate (often used for ADHD) combined with physical activity can help reduce severe tiredness in people with advanced cancer who are receiving immunotherapy. About 212 patients with metastatic cancer will take part. The goa…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
Can a simple sheet improve cancer conversations?
Knowledge-focused OngoingThis study tests two different information sheets to see which one helps advanced cancer patients and their caregivers communicate better with their doctors. About 207 patients and their caregivers will use either a question prompt sheet or a general information sheet during thei…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:50 UTC
-
Cancer patients and caregivers share their room preferences to improve clinic visits
Knowledge-focused OngoingThis study looks at whether cancer patients and their caregivers prefer to wait in an exam room or a waiting room when they visit a supportive care clinic. Researchers will ask about their preferences to understand how to make visits more comfortable. About 406 people with advanc…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:45 UTC
-
Cancer's hidden cost: study reveals financial burden on patients
Knowledge-focused OngoingThis study looks at how serious money problems are for people with advanced cancer. Cancer care can be very expensive, and the stress from debt and high costs may make physical symptoms and quality of life worse. About 141 patients will fill out a short survey to measure their fi…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC